Why Drug Development Still Lacks Integration
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
False
Advertisement
Small Molecules
The Power List 2026 is Live
July 21, 2026
We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality
2 min read
The Grand Winner
July 6, 2026
IMA Active’s DOMINA has been voted the Grand Winner of The Medicine Maker Innovation Awards 2025
6 min read
Reformulating the Future of Small Molecules
June 30, 2026
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
1 min read
Rewriting the Neuroscience Playbook
By James Strachan
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
The Case for Simulating Pregnancy
By Jessica Allerton
June 2, 2026
Why drug trials exclude pregnant women – and how simulation could change that
7 min read
Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
What Sponsors Get Wrong When Initiating an Oncology Study
By Luke Gill, Claudio Hegenberger
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read